
Protein Discovery Could Reverse Brain Aging, Study Finds
Scientists in Singapore have identified a protein that can restore aging brain cells' ability to regenerate, potentially protecting memory and learning as we grow older. The breakthrough could lead to treatments that slow or reverse cognitive decline.
Your brain's ability to create new cells doesn't have to fade with age, thanks to a protein scientists just figured out how to harness.
Researchers at the National University of Singapore have discovered that a protein called DMTF1 acts like a master switch for brain regeneration. When they boosted this protein in aging neural stem cells, the cells regained their youthful ability to multiply and create new neurons.
The finding matters because neural stem cells are your brain's renewal system. They generate fresh neurons that help you learn new skills and form memories. As you age, these stem cells gradually lose their regenerative power, contributing to the cognitive decline many people experience.
Dr. Derrick Ong and his team studied neural stem cells from humans and laboratory models designed to mimic premature aging. They discovered that DMTF1 levels dropped significantly in aged cells. When they restored the protein, something remarkable happened: the cells bounced back.
The protein works by activating helper genes that loosen tightly wound DNA, allowing growth genes to turn on. Without DMTF1, this process stalls and stem cells can't effectively renew themselves.

The research, published in Science Advances in February 2026, focused on cells affected by telomere dysfunction. Telomeres are protective caps on chromosomes that shorten each time a cell divides, a hallmark of aging.
Why This Inspires
This discovery opens a door that many scientists thought might stay closed. The idea that we could one day take a treatment to help our brains maintain their regenerative abilities challenges the assumption that cognitive decline is inevitable.
The research team is now working to identify small molecules that could safely boost DMTF1 activity without increasing cancer risk. While the current results come from laboratory experiments, the framework provides a clear path forward.
Dr. Yajing Liang, the study's first author, acknowledges the work is still in early stages. But the findings give researchers a roadmap for understanding how molecular changes affect brain cell behavior as we age.
The ultimate goal is developing therapies that help aging brains keep producing the new cells needed for learning and memory. For the millions of people worried about maintaining their cognitive health as they grow older, that's a future worth getting excited about.
Based on reporting by Science Daily
This story was written by BrightWire based on verified news reports.
Spread the positivity!
Share this good news with someone who needs it

